D-2 DOPAMINE-RECEPTORS INHIBIT RELEASE OF ASPARTATE AND GLUTAMATE IN RAT RETINA

被引:0
|
作者
KAMISAKI, Y
HAMAHASHI, T
MITA, C
ITOH, T
机构
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Release of endogenous Asp, Glu and gamma-aminobutyric acid (GABA) has been investigated using synaptosomes prepared from rat retina. Exposure in superfusion to a depolarizing concentration of KCl (30 mM) evoked overflow of Asp and Glu, which were almost entirely Ca-dependent. However, 70% of the GABA release was Ca-independent. Dopamine (DA) almost completely inhibited the K+-evoked release of Asp and Glu in a concentration-dependent manner, but the release of GABA was only partly inhibited. The potencies of DA (IC50) to Asp and Glu release were 12 and 30 nM, respectively. A selective D-2 receptor antagonist, S-sulpiride, counteracted the DA-induced inhibition of Asp and Glu release, but a selective D-1 antagonist, SCH 23390, showed no effect. The data suggest that D-2 dopamine receptors located on the Asp and Glu neurons in rat retina may inhibit the release of these excitatory amino acids.
引用
收藏
页码:634 / 638
页数:5
相关论文
共 50 条
  • [21] OF THE RAT D-2 AND D-3 DOPAMINE-RECEPTORS IN INSECT CELLS USING THE BACULOVIRUS SYSTEM
    WOODCOCK, C
    GRABER, SG
    ROONEY, BC
    STRANGE, PG
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1995, 23 (01) : S93 - S93
  • [22] NO CHANGE IN NEOSTRIATAL D-2 DOPAMINE-RECEPTORS AFTER NMDA LESIONS OF RAT PREFRONTAL CORTEX
    BRIDGE, S
    CHRISTIE, MJ
    BEART, PM
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1986, 24 (06) : 1829 - 1832
  • [23] D-2 AND D-3 DOPAMINE-RECEPTORS IN MURINE EMBRYONAL DEVELOPMENT
    FISHBURN, CS
    BEDFORD, M
    LONAI, P
    FUCHS, S
    JOURNAL OF NEUROCHEMISTRY, 1994, 63 : S2 - S2
  • [24] APORPHINE ENANTIOMERS - INTERACTIONS WITH D-1 AND D-2 DOPAMINE-RECEPTORS
    GOLDMAN, ME
    KEBABIAN, JW
    MOLECULAR PHARMACOLOGY, 1984, 25 (01) : 18 - 23
  • [25] LACK OF DISCRIMINATION BY AGONISTS FOR D-2 AND D-3 DOPAMINE-RECEPTORS
    BURRIS, KD
    PACHECO, MA
    FILTZ, TM
    KUNG, MP
    KUNG, HF
    MOLINOFF, PB
    NEUROPSYCHOPHARMACOLOGY, 1995, 12 (04) : 335 - 345
  • [26] EXPRESSION OF D-2 DOPAMINE-RECEPTORS IN THE YEAST S-POMBE
    PRESLAND, JP
    STRANGE, PG
    BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 : U147 - U147
  • [27] D-2 DOPAMINE-RECEPTOR MESSENGER-RNA IS ALTERED TO A GREATER EXTENT BY BLOCKADE OF GLUTAMATE RECEPTORS THAN BY BLOCKADE OF DOPAMINE-RECEPTORS
    QIN, ZH
    ZHOU, LW
    WEISS, B
    NEUROSCIENCE, 1994, 60 (01) : 97 - 114
  • [28] INTERACTION OF PERMANENTLY CHARGED METOCLOPRAMIDE ANALOGS WITH D-2 DOPAMINE-RECEPTORS
    FAROOQUI, T
    BROOKS, K
    HARROLD, MW
    MILLER, DD
    WALLACE, LJ
    URETSKY, NJ
    GENERAL PHARMACOLOGY, 1994, 25 (08): : 1577 - 1584
  • [29] EFFECT OF CALCIUM-CHANNEL BLOCKERS ON NOREPINEPHRINE RELEASE AND MODULATION BY PREJUNCTIONAL D-2 DOPAMINE-RECEPTORS
    FRIEDMAN, DJ
    DUCKLES, SP
    LIFE SCIENCES, 1994, 54 (21) : 1545 - 1557
  • [30] RELEASE-REGULATING D-2 DOPAMINE-RECEPTORS ARE LOCATED ON STRIATAL GLUTAMATERGIC NERVE-TERMINALS
    MAURA, G
    GIARDI, A
    RAITERI, M
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1988, 247 (02): : 680 - 684